Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Xenon Pharmaceuticals Inc shares valued at $770,912 were sold by AULIN SHERRY on Dec 18 ’24. At $41.21 per share, AULIN SHERRY sold 18,709 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, SHERRY AULIN purchased 18,709 shares, netting a total of over 770,909 in proceeds.
Before that, PATOU GARY had sold 4,891 shares from its account. In a trade valued at $200,947, the Director traded Xenon Pharmaceuticals Inc shares for $41.08 each. Upon closing the transaction, the insider’s holdings decreased to 4,891 shares, worth approximately $0.95 million.
Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early October. As of January 04, 2024, Citigroup has initiated its “Buy” rating for XENE. Earlier on December 08, 2023, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for XENE stock.
Analyzing XENE Stock Performance
During the last five days, there has been a surge of approximately 4.55%. Over the course of the year, Xenon Pharmaceuticals Inc shares have jumped approximately 2.47%. Shares of the company reached a 52-week high of $42.23 on 01/02/25 and a 52-week low of $39.39 on 01/02/25. A 50-day SMA is recorded $41.29, while a 200-day SMA reached $40.66. Nevertheless, trading volume fell to 0.55 million shares from 0.3 million shares the previous day.
Support And Resistance Levels for Xenon Pharmaceuticals Inc (XENE)
According to the 24-hour chart, there is a support level at 38.96, which, if violated, would cause prices to drop to 37.76. In the upper region, resistance lies at 41.80. The next price resistance is at 43.44. RSI (Relative Strength Index) is 49.66 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.11, which suggests the price will decrease in the coming days. Percent R is at 51.38%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
